Finding the Prevalence of ADHD in Undiagnosed Young AdultsNCT06383260
Assessing the Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Undiagnosed Young Adults:A Cross Sectional Study
An observational study of Finding the Prevalence of ADHD in Undiagnosed Young Adults, run by Jinnah Sindh Medical University at 1 site in Pakistan.
Trial summary
To asses the prevalence of Attention deficit hyperactivity disrorder in undiagnosed young adults. Read more about this study
- Who is it for?
- Ages 18 to 24 years
- Conditions the study is for
- Finding the Prevalence of ADHD in Undiagnosed Young Adults
- What is being tested?
- Behavioral diagnostic
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 200 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Jul 2023to 1 Sep 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 24 years
- All sexes
- Adult
Study population: Young adults between age group of 18-24
Who may be able to join
- undiagnosed
Who cannot join
- diagnosed with any mental disability
Trial locations and contacts
1 site in 1 country.
About this study
To asses the prevalence of Attention deficit hyperactivity disrorder in undiagnosed young adults.
Read the detailed description
Finding the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) in undiagnosed young adults using the questionnaire provided by WHO ,
- Being tested
- Behavioral diagnostic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Behavioral diagnosticBehavioural
Diagnosing the behavioral pattern
| Study group | Role | What they receive |
|---|---|---|
| Age group | 18-20 21-22 22-24 | |
| ASRS V1.1 scores(%) | Score of Ahdh self report scale questionnaire Receives: Behavioral: Behavioral diagnostic | |
| ADHD symptom prevalence | People who got more than 4 in part A of questionnaire and more than 6 in Part B Receives: Behavioral: Behavioral diagnostic |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assess the prevalence of undiagnosed ADHD in Young adults
To find out the prevalence of ADHD in Young adults
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2024
- Study start1 Jul 2023
- Primary completion1 Sep 2023
- Study completion1 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Finding the Prevalence of ADHD in Undiagnosed Young AdultsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jinnah Sindh Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aina Marzia Syed, Jinnah Sindh Medical University
- Investigators
- Aina M Syed, Principal investigator, Jinnah Sindh Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06383260
- Sponsor's protocol ID
- 009-0001-7719-1189
- Status last verified
- Apr 2024
- First submitted
- 21 Apr 2024
- Last updated
- 25 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessing the Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Undiagnosed Young Adults:A Cross Sectional Study
- ClinicalTrials.gov ID
- NCT06383260
- Acronym / sponsor ID
- 009-0001-7719-1189
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Jinnah Sindh Medical UniversityUniversity, hospital or other
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 1 Sep 2023 (actual)
- Study completion
- 1 Sep 2023 (actual)
- First posted
- 25 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To asses the prevalence of Attention deficit hyperactivity disrorder in undiagnosed young adults.
Detailed description
Finding the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) in undiagnosed young adults using the questionnaire provided by WHO ,
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Age group | – | –18-20 21-22 22-24 |
| ASRS V1.1 scores(%) | – | Behavioral: Behavioral diagnosticScore of Ahdh self report scale questionnaire |
| ADHD symptom prevalence | – | Behavioral: Behavioral diagnosticPeople who got more than 4 in part A of questionnaire and more than 6 in Part B |
Who may qualify
- Ages
- 18 to 24 years
- Sex
- All
- Age groups
- Adult
- Study population
- Young adults between age group of 18-24
Key inclusion criteria (1 listed)
- undiagnosed
Key exclusion criteria (1 listed)
- diagnosed with any mental disability
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Behavioral diagnosticDiagnosing the behavioral pattern | Behavioural | ADHD symptom prevalence, ASRS V1.1 scores(%) |
Primary outcome
Assess the prevalence of undiagnosed ADHD in Young adults
Time frame: 2 months
To find out the prevalence of ADHD in Young adults
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Apr 2024.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Aina M Syed principal investigator
Jinnah Sindh Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Finding the Prevalence of ADHD in Undiagnosed Young Adults, run by Jinnah Sindh Medical University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assess the prevalence of undiagnosed ADHD in Young adults (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2024.